Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Denfivontinib by Genosco for Relapsed Acute Myeloid Leukemia: Likelihood of Approval
Denfivontinib is under clinical development by Genosco and currently in Phase I for Relapsed Acute Myeloid Leukemia. According to GlobalData,...
Denfivontinib by Genosco for Refractory Acute Myeloid Leukemia: Likelihood of Approval
Denfivontinib is under clinical development by Genosco and currently in Phase I for Refractory Acute Myeloid Leukemia. According to GlobalData,...
Cevidoplenib by Genosco for Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura): Likelihood of Approval
Cevidoplenib is under clinical development by Genosco and currently in Phase II for Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura). According...